Fibroblast growth factor 21 as a circulating biomarker at various stages of colorectal carcinogenesis
出版年份 2018 全文链接
标题
Fibroblast growth factor 21 as a circulating biomarker at various stages of colorectal carcinogenesis
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 119, Issue 11, Pages 1374-1382
出版商
Springer Nature
发表日期
2018-11-08
DOI
10.1038/s41416-018-0280-x
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Strongly enhanced colorectal cancer risk stratification by combining family history and genetic risk score
- (2018) Korbinian Weigl et al. Clinical Epidemiology
- The Metabolic Syndrome, Inflammation, and Colorectal Cancer Risk: An Evaluation of Large Panels of Plasma Protein Markers Using Repeated, Prediagnostic Samples
- (2017) Sophia Harlid et al. MEDIATORS OF INFLAMMATION
- Obesity, Inflammation, and Cancer
- (2016) Tuo Deng et al. Annual Review of Pathology-Mechanisms of Disease
- A prospective study of soluble receptor for advanced glycation end-products and colorectal cancer risk in postmenopausal women
- (2016) Liang Chen et al. Cancer Epidemiology
- Cancer metabolism at a glance
- (2016) Alexei Vazquez et al. JOURNAL OF CELL SCIENCE
- Inflammatory networks underlying colorectal cancer
- (2016) Audrey Lasry et al. NATURE IMMUNOLOGY
- Prolongevity hormone FGF21 protects against immune senescence by delaying age-related thymic involution
- (2016) Yun-Hee Youm et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Diagnostic value of interleukin-8 in colorectal cancer: A case-control study and meta-analysis
- (2016) Wen-Jun Jin et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Plasma Inflammatory Markers and Risk of Advanced Colorectal Adenoma in Women
- (2015) M. Song et al. Cancer Prevention Research
- Abstract 1577: Levels of Fibroblast Growth Factor 21 (FGF21) in serum as diagnostic biomarker in patients with breast cancer
- (2015) Maria Elena Knott et al. CANCER RESEARCH
- FGF21 is not required for glucose homeostasis, ketosis or tumour suppression associated with ketogenic diets in mice
- (2015) Kerstin Stemmer et al. DIABETOLOGIA
- Chronic inflammation and risk of colorectal and other obesity-related cancers: The health, aging and body composition study
- (2015) Monika Izano et al. INTERNATIONAL JOURNAL OF CANCER
- Evaluation of pro-inflammatory markers plasma C-reactive protein and urinary prostaglandin-E2 metabolite in colorectal adenoma risk
- (2015) James R. Davenport et al. MOLECULAR CARCINOGENESIS
- Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23
- (2015) Chiara Degirolamo et al. NATURE REVIEWS DRUG DISCOVERY
- Biomarker patterns of inflammatory and metabolic pathways are associated with risk of colorectal cancer: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)
- (2014) Krasimira Aleksandrova et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- A Prospective Study of Macrophage Inhibitory Cytokine-1 (MIC-1/GDF15) and Risk of Colorectal Cancer
- (2014) Raaj S. Mehta et al. JNCI-Journal of the National Cancer Institute
- Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability
- (2014) Erika Assarsson et al. PLoS One
- Strong effects of genetic and lifestyle factors on biomarker variation and use of personalized cutoffs
- (2014) Stefan Enroth et al. Nature Communications
- Comparative Evaluation of Immunochemical Fecal Occult Blood Tests for Colorectal Adenoma Detection
- (2013) Sabrina Hundt ANNALS OF INTERNAL MEDICINE
- Activation of Liver FGF21 in hepatocarcinogenesis and during hepatic stress
- (2013) Chaofeng Yang et al. BMC GASTROENTEROLOGY
- A prospective study of plasma inflammatory markers and risk of colorectal cancer in men
- (2013) M Song et al. BRITISH JOURNAL OF CANCER
- Development and Validation of a Scoring System to Identify Individuals at High Risk for Advanced Colorectal Neoplasms Who Should Undergo Colonoscopy Screening
- (2013) Sha Tao et al. Clinical Gastroenterology and Hepatology
- Mechanisms linking obesity, inflammation and altered metabolism to colon carcinogenesis
- (2012) E. Yehuda-Shnaidman et al. Obesity Reviews
- Advanced Glycation End Products, Soluble Receptor for Advanced Glycation End Products, and Risk of Colorectal Cancer
- (2011) L. Jiao et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- PGC1 Promotes Tumor Growth by Inducing Gene Expression Programs Supporting Lipogenesis
- (2011) K. Bhalla et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma
- (2011) Ying Gao et al. INTERNATIONAL JOURNAL OF CANCER
- AGA Technical Review on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease
- (2010) Francis A. Farraye et al. GASTROENTEROLOGY
- Inflammatory Markers Are Associated With Risk of Colorectal Cancer and Chemopreventive Response to Anti-Inflammatory Drugs
- (2010) Andrew T. Chan et al. GASTROENTEROLOGY
- Low-Dose Aspirin Use and Performance of Immunochemical Fecal Occult Blood Tests
- (2010) Hermann Brenner et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Quantitative Immunochemical Fecal Occult Blood Testing for Colorectal Adenoma Detection: Evaluation in the Target Population of Screening and Comparison With Qualitative Tests
- (2009) Ulrike Haug et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Circulating Levels of Inflammatory Cytokines and Risk of Colorectal Adenomas
- (2008) S. Kim et al. CANCER RESEARCH
- The Interleukin-8 Pathway in Cancer
- (2008) D. J.J. Waugh et al. CLINICAL CANCER RESEARCH
- Aspirin Dose and Duration of Use and Risk of Colorectal Cancer in Men
- (2007) Andrew T. Chan et al. GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More